Status:
COMPLETED
Analysis of the Pachychoroid Phenotype in an Asian Population
Lead Sponsor:
Singapore National Eye Centre
Collaborating Sponsors:
National University Hospital, Singapore
Conditions:
Pachychoroid Disease
Eligibility:
All Genders
45+ years
Brief Summary
The understanding of pachychoroid phenotype is incomplete. It is important to understand the risk of conversion from an uncomplicated pachychoroid phenotype to the pachychoroid disease phenotype, to g...
Detailed Description
The progression of uncomplicated pachychoroid phenotype to pachychoroid disease is not well established and the pathophysiology of these phenotypes remains unknown: specifically if the occurence of pa...
Eligibility Criteria
Inclusion
- Presence of uncomplicated and/or non-neovascular pachychoroid phenotype in at least one eye.
- Subfoveal choroidal thickness \>300 microns on enhanced depth imaging optical coherence tomography for at least one eye
- Male or female patients above 45 years of age
- Willingness to undergo pupil dilation, and protocol- required procedures for both eyes
- Willing to provide written informed consent
Exclusion
- Presence of disorders of the ocular media which interfere with visual acuity and other ocular assessments, including Spectral domain- optical coherence tomography during the study period
- Pregnant or nursing women
Key Trial Info
Start Date :
July 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04498000
Start Date
July 22 2020
End Date
November 30 2023
Last Update
April 17 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore
2
Singapore National Eye Centre
Singapore, Singapore